Aldeyra Therapeutics, Inc.
ALDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$55,851 | -$37,543 | -$62,025 | -$57,776 |
| Dep. & Amort. | $250 | $263 | $259 | $264 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,973 | $5,753 | $8,289 | $7,108 |
| Change in WC | $5,913 | $861 | -$3,444 | $7,439 |
| Other Non-Cash | -$1,494 | $340 | $284 | $409 |
| Operating Cash Flow | -$43,209 | -$30,326 | -$56,637 | -$42,556 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$16 | -$8 |
| Net Acquisitions | $0 | $0 | $16 | $0 |
| Inv. Purchases | -$96,916 | $0 | -$92,938 | $0 |
| Inv. Sales/Matur. | $52,000 | $30,000 | $63,000 | $0 |
| Other Inv. Act. | $0 | $0 | -$16 | $0 |
| Investing Cash Flow | -$44,916 | $30,000 | -$29,955 | -$8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$293 | -$1,043 | $0 | $0 |
| Stock Issued | $121 | $305 | $1,220 | $189,812 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$533 | $0 | $4,685 |
| Financing Cash Flow | -$171 | -$1,270 | $1,220 | $194,496 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$88,296 | -$1,596 | -$85,372 | $151,933 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $142,823 | $144,419 | $229,791 | $77,858 |
| End Cash | $54,527 | $142,823 | $144,419 | $229,791 |
| Free Cash Flow | -$43,209 | -$30,326 | -$56,654 | -$42,564 |